Fundamental Analysis
35 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +17.4% | +0.8% | 2 / 3 | +11.8% | +0.98 pp | +0.03 pp | +10.5% | 1.27 | 6.48 | 6.457 | +11,8% | 35,7 | +17,4% | 6.48 | 5.17 | +25,3% |
| Pts | 0 | 0 | 8 | 4 | 8 | 8 | 0 | 6 | 4 | |||||||
Valuation annotation:Price: 50.000 (close price on 2026-10-19)EPS (TTM): 7.718
Financial charts
1.Revenue & growth
VND bn6.457Q2/26
1.Revenue & growth
VND bn6.457Q2/26
2.Profit & growth
VND bn35,6Q2/26
3.Profit mix (Penman)
VND bn113Q2/26
4.Margins & cost structure
%2.9%Q2/26
5.Returns & cash cycle
% · days6.7%Q2/26
6.Earnings quality & cash
VND bn647Q2/26
7.Asset structure
VND bn4.567Q2/26
8.Funding & debt health
VND bn · times4.567Q2/26
9.Revenue backlog
VND bn40,2Q2/26
10.Valuation
times · %8,5×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %3.233Q2/26
Adjusted EPS growth, latest quarter
17.1%
Average adjusted EPS growth, 3 quarters
0.7%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26